Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.4.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-20389.3US
LK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDSORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDSNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDQ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.5.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.5.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GW.5.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.23.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.23.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JE.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JE.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used